Search for: "Dr. Reddy"
Results 221 - 240
of 395
Sorted by Relevance
|
Sort by Date
11 Apr 2012, 4:15 pm
Is Dr. [read post]
31 May 2017, 12:35 pm
I also accept Dr. [read post]
18 Apr 2008, 8:38 pm
Teva and Dr. [read post]
1 Sep 2011, 11:21 am
The security risks of employees using their own smart phones at work http://bit.ly/rrjeYQ Google launches Canadian online movie service bit.ly/pc9Jwb Nokia, Microsoft tap Mosaid to handle huge patent trove bit.ly/n6VT94 Openwave files ITC complaint and US Fed Court lawsuit against Apple & RIM, alleging infringement of various IT patents http://cnet.co/rk5fHK Study: Thermal Imaging Could Be Used to Hack ATM Codes ti.me/pbH0Eg Y Combinator’s Patent Pledge Asks Tech Companies To Grant… [read post]
13 Apr 2009, 5:00 am
Another example is Merck’s authorized generic deal with Dr. [read post]
2 Apr 2007, 9:52 pm
Dr. [read post]
10 Oct 2010, 6:21 am
Also brought within the IPO’s corral is the decision in Dr Reddy’s Laboratories (UK) Ltd v Eli Lilly & Co Ltd [2010] RPC 8 (noted by the IPKat here), in which the Court of Appeal delved into the murky depths of selection invention – asking, in the process, where a wise man would hide a leaf… The sections on supplementary protection certificates has also been updated in light of the decisions of the High Court in Yeda Research and Development Company Ltd… [read post]
1 Jan 2007, 7:45 pm
Three generic manufacturers (Zenith (IVAX), Dr. [read post]
25 Mar 2012, 6:33 am
Whether you are on the branded or generic side, you cannot afford to miss this opportunity because you will: Hear directly from the FDA on how they will implement the abbreviated pathway Benchmark your strategy against market leaders such as Amgen, Dr. [read post]
23 Jun 2011, 11:16 pm
Some of those companies include: Akorn Dr. [read post]
29 Jun 2009, 5:33 pm
And there are a couple of fishing expeditions still in progress: Dr. [read post]
2 Jul 2007, 2:51 pm
Dr. [read post]
17 Oct 2008, 1:32 pm
You can separately subscribe to the Pharma & Biotech edition of the IP Thinktank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Cipro (Ciprofloxacin) - US: CAFC finds no antitrust liability for Hatch-Waxman reverse payment settlements: In Re Ciproflaxacin Hydrochloride Antitrust Litigation… [read post]
25 Apr 2008, 8:32 am
Vidyullatha Reddy (vidyullathareddy@gmail.com). [read post]
23 Dec 2009, 12:40 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/ Highlights this week included: Zyprexa (Olanzapine) – UK: Court of Appeal upholds Justice Floyd’s decision finding Olanzapine patent valid: Dr Reddy’s Laboratories v Eli Lilly (EPLAW) (IPKat) (Managing IP) (PatLit) (GenericsWeb) France: Pharma trade marks under threat - Senate and National Assembly approve law that would allow… [read post]
27 Mar 2009, 8:00 am
; no skulduggery involved in pharma enquiry submission switch says EPO (IPKat) (IAM) India: Public sector IP and socially responsible licensing (Spicy IP) India: Pharma lobby wants a probe into delayed orders (Spicy IP) UK: Euro costs in UK litigation: Actavis UK Ltd v Novartis AG (PatLit) US: Two biosimilars bills introduced in the House: HR 1427, the Promoting Innovation and Access to Life Saving Medicine Act; and H.R. 1548, the Pathway to BioSimilars Act (California Biotech Law Blog) (Managing… [read post]
2 Jan 2019, 2:15 am
How the likelihood of success on the merits should (or should not) be determined and the four factors balanced in a patent infringement case, are areas in which there has been significant disagreement among the judges of the Federal Circuit... [read post]
22 Dec 2016, 8:35 am
| Negative decision for anti-HIV therapy patent: Merck Sharpe & Dohme v Shionogi Co Limited | Book review: Copyright and E-Learning | Friday Fantasies | Fontem see their patent “vaporised” – the dangers of added matter | BREAKING: Antidote found for poisonous priorities | Around the IP blogs | AIPPI Congress Report 5: Antitrust and Pharma - seeking a balance | When the Rolling Stones visited 2120 South Michigan Avenue in Chicago | No measure of success in passing off cup case |… [read post]
13 Jan 2020, 7:55 am
Dr. [read post]
4 Jul 2007, 10:50 pm
If you want to help Duncan in this exciting adventure, email him here with news of the litigation in your jurisdiction.Right: chocks away, as Duncan "Biggles" Bucknell" flies off around the world to service his clientele's international interestsOther scorecards on Duncan's website list the current state of play in the US v Czech Budweiser dispute (here), Ranbaxy's battle with Pfizer over Lipitor (here) and the Eli Lilly/Teva/Dr Reddy's fight over… [read post]
